- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03911765
Effect of Digital Cognitive Training on the Functionality of Older Adults With Mild Cognitive Impairment (MCI)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Mild Cognitive Impairment (MCI) is characterized by decline in one or more cognitive domains, including memory, attention, executive functions, language and visuospatial abilities, and in a significant portion of cases may evolve to Alzheimer's Disease. According to established diagnostic criteria, independence for daily life activities is preserved, but activities are carried out less effectiveness and efficiency, affected subjects usually take more time and make more mistakes, when compared to their pre-morbid performance. Different studies have observed that impairments in functional performance in older adults with MCI are associated with impairments in executive function. This study intends to verify the impact of the use of digital cognitive training for executive function on the functionality of older adults with MCI. Digital cognitive exercises, used in the intervention group, have the primary objective of stimulating executive functions, and will be made available through the Internet using the BrainHQ platform. The active control group will play computer games available online. Both groups will play for 1 hour at least 2 times per week.
After baseline assessments, older adults with MCI will be stratified by age, education, gender, functional measurement and cognitive assessment, and randomly assigned to the intervention group with digital cognitive exercises or to the control group with computer games, in a stepped wedge design. Subjects will be evaluated at baseline and after completing 10 and 20 hours of intervention. After the first 10 hours of intervention both groups will be assigned to the intervention with digital cognitive exercises for additional 10 hours. Both groups will be comparable in terms of personal contact with staff and computer time. Our hypothesis is that the training using digital cognitive exercises will improve the executive function and that this gain has a positive impact on the functionality and accomplishment of the daily life activities of older adults with MCI.
Study Type
Enrollment (Anticipated)
Phase
- Phase 1
Contacts and Locations
Study Contact
- Name: Rogério Panizzutti
- Phone Number: 55 21999090498
- Email: rpanizzutti@gmail.com
Study Locations
-
-
RJ
-
Rio de Janeiro, RJ, Brazil
- Recruiting
- Universidade Federal do Rio de Janeiro
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age above 65 years old;
- Elderly enrolled in home for aged in wich the research is taking place;
- Montreal Cognitive Assessment above 21 points;
Exclusion Criteria:
- Clinical diagnosis of Alzheimer's Disease;
- Serious medical or neurological condition preventing from participation in the study;
Study Plan
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Executive Function cognitive training
20 hours of digital cognitive training targeting executive function.
|
Digital cognitive exercises, used in the intervention group, have the primary objective of stimulating executive functions, and will be made available through the Internet using the BrainHQ platform.
|
ACTIVE_COMPARATOR: Games
10 hours of computer games c available online which do not involve a high demand in cognitive functions (e.g.
fishing game, pinball game, tetris, etc), followed by 10 hours of of digital cognitive training targeting executive function.
|
Digital cognitive exercises, used in the intervention group, have the primary objective of stimulating executive functions, and will be made available through the Internet using the BrainHQ platform.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Performance in everyday living score change
Time Frame: 3 months
|
Performance in everyday living score change will be measured using Canadian Occupational Performance Measure (COPM). The Canadian Occupational Performance Measure (COPM) has a client-centered design and measures outcomes according to three occupational performance areas (self-care, productivity, and leisure), examining self-perceived changes in the occupational performance of patients through a semistructured interview. At the beginning, patients start by identifying their difficulties according to the three occupational performance areas. They subsequently use a 10-point scale, ranging from not at all crucial (1) to extremely crucial (10), to identify the intensity of certain difficulties. For the top five problems or tasks selected by patients, the interviewer asks them to continue identifying their performance and satisfaction with their performance by using the same 10-point rating scale. |
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Functional status score change
Time Frame: 3 months
|
Functional status score will be measured using the Direct Assessment of Functional Status-Revised (DAFS-R).
DAFS-R assesses seven different domains of functional abilities by requiring the participant to carry out different tasks, two domains will be evaluated: dealing with Finances (score range 0-32) and shopping skills (score range 0-20), with higher scores indicating better functioning.
|
3 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Global cognitive function score change
Time Frame: 3 months
|
Global cognitive function score will be measured using the Montreal Cognitive Assessment (MoCA).
Thirty items assessing multiple cognitive domains are contained in the MoCA: short-term memory (score range 0-5); visuospatial abilities (score range 0-3), cube copy task (score range 0-1); executive functioning (score range 0-1), phonemic fluency (score range 0-1), verbal abstraction (score range 0-2); attention, concentration, and working memory (score range 0-1), serial subtraction (score range 0-3), digits forward (score range 0-1), and digits backward (score range 0-1); language (score range 0-3), and repetition of complex sentences (score range 0-2); orientation to time and place (score range 0-6), with higher scores indicating better cognition.
|
3 months
|
Semantic memory score change
Time Frame: 3 months
|
Semantic memory score will be measured using the Verbal fluency test.
The verbal fluency test is a short test of verbal functioning.
It typically consists of two tasks: category fluency and letter fluency.
In the standard versions of the tasks, participants are given 1 min to produce as many unique words as possible within a semantic category (category fluency) or starting with a given letter (letter fluency).
The participant's score in each task is the number of unique correct words.
|
3 months
|
Selective attention and cognitive flexibility
Time Frame: 3 months
|
Selective attention and cognitive flexibility will be measured using the Stroop Test
|
3 months
|
Sustained attention and set-shifting
Time Frame: 3 months
|
Sustained attention and set-shifting will be measured using the Trial Making Test
|
3 months
|
Depression score change
Time Frame: 3 months
|
Depression score will be measured using the Geriatric Depression Scale - 15 (Short version).
The Geriatric Depression Scale (GDS) is a 30-item self-report assessment used to identify depression in the elderly.
In the Geriatric Depression Scale, questions are answered "yes" or "no."
One point is assigned to each answer and the cumulative score is rated on a scoring grid.
The grid sets a range of 0-9 as "normal", 10-19 as "mildly depressed", and 20-30 as "severely depressed".
|
3 months
|
Qualitative motivation with the computerized training exercise
Time Frame: 3 months
|
Qualitative motivation will be assessed using semi-structured interview
|
3 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 17976113.1.0000.5257
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aging
-
Tuba MadenCompletedAging | Aging Problems | Aging Disorder
-
Radboud University Medical CenterNot yet recruitingAging | Aging Well | Immuno Aging
-
University of Santiago de CompostelaEuropean Regional Development Fund; Center for Industrial Technological Development...Completed
-
TruDiagnosticBlushield USANot yet recruitingAging | Aging Well
-
San Diego State UniversityCompleted
-
Lithuanian Sports UniversityCompletedAging | Healthy AgingLithuania
-
University of West AtticaNot yet recruiting
-
University of Santiago de CompostelaAgencia Estatal de Investigación, SpainRecruiting
-
Beijing HospitalBGI-ShenzhenCompletedAging | Healthy Aging
-
Amazentis SAproDERM GmbHCompleted
Clinical Trials on digital cognitive training
-
Samsung Medical CenterCompleted
-
University of FloridaNational Institute on Aging (NIA); National Center for Advancing Translational...RecruitingCognitive DysfunctionUnited States
-
Istituto Nazionale di Ricovero e Cura per AnzianiCompletedCOVID-19 | Parkinson Disease | Mild Cognitive ImpairmentItaly
-
SangathHarvard Medical School (HMS and HSDM); London School of Hygiene and Tropical...Completed
-
Beijing Anzhen HospitalBeijing Wispirit Technology Co., LtdActive, not recruitingCoronary Heart Disease | Mild Cognitive ImpairmentChina
-
Nina AyalaThe Miriam HospitalRecruitingPostpartum Psychiatric DisordersUnited States
-
St. Olavs HospitalUniversity of California, Berkeley; Norwegian University of Science and Technology and other collaboratorsActive, not recruiting
-
Vicore Pharma ABCurebase Inc.Active, not recruitingGeneralized Anxiety Disorder | Pulmonary FibrosisUnited States
-
Peking University First HospitalShenzhen Zeen Health Technology Co., Ltd.Not yet recruiting
-
Science and Research Centre KoperAlbert Einstein College of Medicine; University of Primorska; Vrije Universiteit...CompletedEffects of Cognitive Intervention on Cognition, Mobility and Brain Electrocortical Activity (GIBKOP)Cognitive Impairment | Aging | Cognitive Decline | Motor Coordination or FunctionSlovenia